1. Scrip

Sun finally gains control of Taro as takeover saga draws to a close

 
• By Anju Ghangurde

Sun Pharmaceutical Industries of India has completed the buyout of a controlling interest in Taro Pharmaceutical Industries, bringing to an end an acrimonious takeover battle spanning more than three years.

Sun Pharmaceutical Industries of India has completed the buyout of a controlling interest in Taro Pharmaceutical Industries, bringing to an end an acrimonious takeover battle spanning more than three years.

Sun said that its subsidiaries had raised their holding in Taro to 48.7% (from about 36%) and voting rights to...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Scrip

Bayer Bags First Global Okay For Hot Flashes Therapy

 
• By Kevin Grogan

Lynkuet will compete with Astellas's Veozah/Veoza

China’s Biotechs Were The Small-Cap Rising Stars In H1 2025

 
• By Andrew McConaghie

The list of small-cap companies with the fastest-rising share prices so far this year is dominated by Chinese companies, underscoring their growing contribution to the global biopharma ecosystem.

In Brief: Soleno To Raise $200m To Boost Vykat XR Launch

 
• By Manas Mishra

Soleno Therapeutics will raise about $200m gross proceeds from an offering of 2.35m of its common stock to fund the commercialization of Vykat XR, which became the first drug for Prader-Willi syndrome to gain US approval on March 26.